@article {819,
	title = {Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin},
	journal = {Am J Hematol},
	volume = {72},
	year = {2003},
	note = {0361-8609 (Print) Case Reports Journal Article},
	month = {Mar},
	pages = {220 - 2},
	abstract = {A male patient had a relapse of myelodysplastic syndrome (MDS) 2 years after BMT from a female matched unrelated donor. Conventional cytogenetics, FISH, and short-tandem repeat chimerism analysis proved a relapse of donor origin. He underwent reduced-intensity BMT after a conditioning with fludarabine and busulfan, since he had impaired renal, liver, and pulmonary functions. Chimerism analysis on day 28 after the second BMT showed mixed chimerism of the first and the second donors, which later turned to full second-donor chimerism on day 60. He developed grade II acute GVHD of the skin and cytomegalovirus reactivation, but both were improved with methylprednisolone and ganciclovir, respectively. He remains in complete remission 6 months after the second BMT. Reduced-intensity second BMT from an alternative donor appeared to be a tolerable treatment option for donor-derived leukemia/MDS after the first conventional transplantation.},
	keywords = {*Tissue Donors, Adult, Antineoplastic Combined Chemotherapy Protocols / administration \&, Bone Marrow Transplantation / *adverse effects / *methods, Cyclosporine / therapeutic use, dosage / adverse effects, Graft vs Host Disease / diagnosis / prevention \& control, Humans, Immunosuppressive Agents / therapeutic use, Male, Methotrexate / therapeutic use, Myelodysplastic Syndromes / *etiology / genetics / *therapy, Recurrence, Remission Induction, Transplantation Chimera, Transplantation Conditioning},
	author = {Komeno,Y. and Kanda,Y. and Kandabashi,K. and Kawazu,M. and Goyama,S. and Takeshita,M. and Nannya,Y. and Niino,M. and Nakamoto,T. and Kurokawa,M. and Tsujino,S. and Ogawa,S. and Aoki,K. and Chiba,S. and Motokura,T. and Hirai,H.}
}
